Top Growth Trends in the Real-Time PCR, Digital PCR And End-Point PCR Market: Key Insights and Opportunities for 2025-2034
Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!
How has the real-time pcr, digital pcr and end-point pcr market grown over the years?
The real-time PCR, digital PCR, and end-point PCR market has expanded significantly, projected to grow from $38.37 billion in 2024 to $41.88 billion in 2025 at a CAGR of 9.2%. Key historical growth drivers include standardized PCR protocols, applications in personalized medicine, contributions to drug discovery, and its role in forensic and paternity testing.
What Is the forecasted market size and growth rate for the real-time pcr, digital pcr and end-point pcr market?
The real-time PCR, digital PCR, and end-point PCR market is expected to experience strong growth, reaching $60.91 billion by 2029 at a CAGR of 9.8%. Market growth is driven by expanding molecular diagnostics, increased infectious disease testing, growing genetic testing demand, research and forensic applications, and point-of-care PCR advancements. Key trends include the emergence of digital assays, multiplex PCR innovations, automation, miniaturization, and high-throughput PCR systems.
Get your real-time pcr, digital pcr and end-point pcr market report here!
What are the major factors driving growth in the real-time pcr, digital pcr and end-point pcr market?
The escalation in infectious disease cases is anticipated to boost the expansion of real-time PCR, digital PCR, and end-point PCR markets. These diseases, resulting from the invasion and multiplication of harmful microorganisms like bacteria, fungi, viruses, and parasites, make use of real-time PCR, digital PCR, and end-point PCR for the quantification of specific pathogens or their genetic material, tracking disease progression, and swift diagnosis of infections such as HIV, hepatitis, respiratory viruses, and tuberculosis. For instance, the global HIV count spiked to 39 million in 2022, a 3.17% increase from 37.7 million in 2020, according to UNAIDS in July 2023. Plus, approximately 1.3 million fresh HIV infections were reported in 2022. Additionally, in March 2023, the Centers for Disease Control and Prevention stated that tuberculosis (TB) cases reported in the US climbed to 8,300 in 2022 from 7,874 in 2021. Due to these statistical increases, the cephalosporin market is expected to grow correspondingly.
Real-Time PCR, Digital PCR And End-Point PCR Market Driver: The Surge in Chronic Diseases Set to Accelerate PCR Technologies Growth
What key areas define the segmentation of the global real-time pcr, digital pcr and end-point pcr Market?
The real-time pcr, digital pcr and end-point pcr market covered in this report is segmented –
1) By Product: Instruments, Consumables And Reagents, Software And Services
2) By Technology: Quantitative, End-Point Polymerase Chain Reaction (PCR), Digital
3) By Applications: Clinical, Research, Forensic, Other Applications
4) By End User: Hospital, Diagnostic Labs, Pharma, Biotech, Contract Research Organizations
Subsegments:
1) By Instruments: Real-Time PCR Systems, Digital PCR Systems, End-Point PCR Systems
2) By Consumables And Reagents: PCR Plates And Tubes, Primers And Probes, PCR Master Mix, DNA Polymerases And Nucleotides
3) By Software And Services: Analysis Software, Data Management Software, Calibration And Maintenance Services, Training And Support Services
Get your free sample now – explore exclusive market insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=13296&type=smp
What are the top market players propelling the growth of the real-time pcr, digital pcr and end-point pcr industry?
Major companies operating in the real-time PCR, digital PCR and end-point PCR market report are F. Hoffmann La Roche Ltd., Merck & Co. Inc., Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Becton Dickinson and Co., GE HealthCare Technologies Inc., Agilent Technologies Inc., bioMérieux S.A., Bio-Rad Laboratories Inc., QIAGEN N.V., Eppendorf Group, Promega Corporation, Meridian Bioscience Inc., Takara Bio Inc., Cole-Parmer Instrument Company LLC, Bioneer Corporation, Enzo Life Sciences Inc., Analytik Jena AG, Fluidigm Corporation, Elitech Group SAS, Microsynth AG, Stilla Technologies SAS, HTG Molecular Diagnostics Inc., AITbiotech Pte Ltd., Bio Molecular Systems, JN Medsys Pte Ltd., Biomeme Inc.
What are the key trends shaping the future of the real-time pcr, digital pcr and end-point pcr market?
Leading enterprises in the real-time PCR, digital PCR, and end-point PCR markets are formulating novel products through the application of cutting-edge technologies, like digital polymerase chain reaction (dPCR) technology. This is done to gain a profound comprehension of a patient’s cancer, genetic disease, or infectious conditions. Digital polymerase chain reaction (dPCR) technology, an enhanced biotechnological iteration of the traditional polymerase chain reaction (PCR) methods, is capable of quantifying and clonally amplify strands of nucleic acid such as DNA, cDNA, or RNA. For example, Roche Diagnostics, an American pharmaceutical and medical device producer, in August 2022, unveiled its next-generation PCR system – the Digital LightCycler System. This system aims to facilitate early diagnosis and treatment of several chronic and genetic diseases. It is engineered to independently manage data and automate workflow, thus doing away with the need for external computations, software, and processors. A fusion of three nano well plate configurations, six high-end optical channels, and 5x concentrated DNA and RNA master mixes aligns high precision and sensitivity. With the addition of the Digital LightCycler System to its diagnostic platform range, Roche brings forth advanced technology, tailor-made clinical applications, and fully automated workflow.
Unlock exclusive market insights – purchase your research report now for a swift delivery!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=13296
What regions are dominating the real-time pcr, digital pcr and end-point pcr market growth?
North America was the largest region in the real-time PCR, digital PCR, and end-point PCR market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the real-time PCR, digital PCR and end-point PCR market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Browse Through More Similar Reports By The Business Research Company:
PCR And Realtime PCR Testing Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/pcr-and-realtime-pcr-testing-global-market-report
Location-Based Services (LBS) And Real-Time Location Systems (RTLS) Global Market Report 2024
Polymerase Chain Reactions (PCR) Devices, Reagents And Uses Global Market Report 2024
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
